From this week's issue of Chemical and Engineering News:
- Cover story: the year in pharma
- Positive review of Scott Gottlieb, the new FDA chief (article by Lisa Jarvis)
- The year in drug price shenanigans (article by Lisa Jarvis)
- Neat diamine synthesis! (article by Stephen K. Ritter)
- Interesting article by Celia Henry Arnaud about the revolt against ABET accreditation from the chemical engineering departments of Caltech and Stanford
- EPA attempting to get animals out of toxicity testing (article by Britt Erickson)
- Watching Big Pharma get out of employing R&D in China is odd (article by Jean-François Tremblay)
- I bet this is a temporary shift, and overall Big Pharma scientist headcount (or additional purchased headcount) will stay flat or up over the next 5-10 years
- "Graduate students protest U.S. tax plan" (article by Andrea Widener)
No comments:
Post a Comment
looks like Blogger doesn't work with anonymous comments from Chrome browsers at the moment - works in Microsoft Edge, or from Chrome with a Blogger account - sorry! CJ 3/21/20